4.5 Article

Dihydrolipoamide dehydrogenase and cAMP are associated with cadmium-mediated Leydig cell damage

Journal

TOXICOLOGY LETTERS
Volume 205, Issue 2, Pages 183-189

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.toxlet.2011.06.003

Keywords

Cadmium; Leydig cell; Dihydrolipoamide dehydrogenase; cAMP

Categories

Funding

  1. National Natural Science Foundation of China [31000663, 81070477]
  2. Program for New Century Excellent Talents in University [NCET-08-0611]

Ask authors/readers for more resources

Cadmium (Cd) directly inhibits testosterone production in Leydig cells, but its mechanism is still unclear. To further explore the signaling pathway of Cd-mediated toxicity to Leydig cells, various concentrations of Cd were cultured with R2C cells for 24h, and two-dimensional gel electrophoresis (2DE)-based proteomics profiling was used to analyze the change of protein expressions. Cd caused a concentration-dependent inhibition of cell viability with IC25, IC50 and IC75 of 2.42 x 10(-5) M, 4.83 x 10(-5) M and 7.39 x 10(-5) M. respectively. Cd significantly reduced progesterone production and mitochondrial membrane potential (Delta Psi(m)) in a concentration-dependent manner. 2DE-based proteomics showed 34 protein spots with altered expression by 2-folds or more, and dihydrolipoamide dehydrogenase (OLD) was the hub in the network of these altered proteins. Real-time polymerase chain reaction (PCR) and Western blotting showed that Cd downregulated the expression of DLD. Cd also decreased intracellular levels of cyclic adenosine monophosphate (cAMP). The results suggest that DLD and cAMP may be key elements related to Cd toxicity to Leydig cells. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available